H
28.23
-1.30 (-4.40%)
| 前收盘价格 | 29.53 |
| 收盘价格 | 29.31 |
| 成交量 | 384,938 |
| 平均成交量 (3个月) | 711,754 |
| 市值 | 1,620,026,496 |
| 市盈率 (P/E TTM) | 11.25 |
| 预期市盈率 (P/E Forward) | 8.31 |
| 价格/销量 (P/S) | 2.39 |
| 股市价格/股市净资产 (P/B) | 2.57 |
| 52周波幅 | |
| 利润日期 | 28 Apr 2025 - 2 May 2025 |
| 营业毛利率 | 20.36% |
| 营业利益率 (TTM) | 27.69% |
| 稀释每股收益 (EPS TTM) | 2.51 |
| 季度收入增长率 (YOY) | 19.50% |
| 季度盈利增长率 (YOY) | 85.90% |
| 总债务/股东权益 (D/E MRQ) | 27.52% |
| 流动比率 (MRQ) | 3.31 |
| 营业现金流 (OCF TTM) | 219.82 M |
| 杠杆自由现金流 (LFCF TTM) | 143.91 M |
| 资产报酬率 (ROA TTM) | 13.17% |
| 股东权益报酬率 (ROE TTM) | 25.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Harmony Biosciences Holdings, I | 看涨 | 看涨 |
AIStockmoo 评分
0.2
| 分析师共识 | 5.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 1.5 |
| 技术平均移动指标 | -1.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.20 |
|
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.61% |
| 机构持股比例 | 97.90% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Valor Management Llc | 31 Dec 2024 | 6,618,033 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 70.00 (HC Wainwright & Co., 147.96%) | 购买 |
| 中 | 52.50 (85.97%) | |
| 低 | 44.00 (Mizuho, 55.86%) | 购买 |
| 平均值 | 54.75 (93.94%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 32.41 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Needham | 10 Apr 2025 | 50.00 (77.12%) | 购买 | 28.99 |
| 08 Apr 2025 | 50.00 (77.12%) | 购买 | 28.13 | |
| HC Wainwright & Co. | 08 Apr 2025 | 70.00 (147.96%) | 购买 | 28.13 |
| 27 Feb 2025 | 70.00 (147.96%) | 购买 | 32.75 | |
| Mizuho | 18 Mar 2025 | 44.00 (55.86%) | 购买 | 34.78 |
| 20 Feb 2025 | 42.00 (48.78%) | 购买 | 34.89 | |
| Deutsche Bank | 11 Feb 2025 | 55.00 (94.83%) | 购买 | 37.74 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合